Karen Sclama, PA
Physician Assistant · Lincoln, RINPI 1144297698
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 174 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 15.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,065 and has fallen 97.8% since, to $23 in 2025. Among physician assistant clinicians in RI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 174 payments — averaging $19.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$521
- AbbVie$510
- Novo Nordisk$306
- Viiv Healthcare Company$228
- Nestle Healthcare Nutrition Inc.$214
- Amgen$175
- plus $1K from 29 others
What the payments were for
- Food & beverage$3,411100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 30 | $521 |
| AbbVie | 25 | $510 |
| Novo Nordisk | 15 | $306 |
| Viiv Healthcare Company | 12 | $228 |
| Nestle Healthcare Nutrition Inc. | 8 | $214 |
| Amgen | 8 | $175 |
| Merck | 9 | $172 |
| Teva Pharmaceuticals USA, Inc. | 10 | $170 |
| GSK | 10 | $167 |
| Pfizer | 7 | $118 |
| Biohaven Pharmaceuticals, Inc. | 5 | $92 |
| Amarin Pharma, Inc. | 3 | $64 |
| Inspire Medical Systems, Inc. | 1 | $61 |
| Xeris Pharmaceuticals, Inc. | 3 | $54 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $53 |
| Lilly USA, LLC | 2 | $51 |
| Exact Sciences | 2 | $47 |
| Sanofi-aventis U.S. LLC | 2 | $43 |
| Insmed, Inc. | 2 | $40 |
| Insightec,inc | 1 | $32 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $30 |
| Boehringer Ingelheim | 1 | $29 |
| Dexcom, Inc. | 1 | $27 |
| Eisai Inc. | 1 | $27 |
| Ultragenyx Pharmaceutical Inc. | 1 | $23 |
| Esperion Therapeutics, Inc. | 1 | $20 |
| Lexicon Pharmaceuticals, Inc. | 1 | $20 |
| Gilead | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $15 |
| Actelion Pharmaceuticals US, Inc. | 1 | $15 |
| Mylan Specialty L.p. | 1 | $15 |
| Bayer | 1 | $15 |
| Sanofi Pasteur Inc. | 1 | $13 |
| Almatica Pharma LLC | 1 | $12 |
| Johnson & Johnson | 1 | $11 |
How this compares
$3,411 in reported general payments places this provider in the 90th percentile of 481 physician assistant providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 35 | $53,346 |
| XareltoRivaroxaban | 23 | $27,900 |
| EliquisApixaban | 25 | $24,376 |
| MounjaroTirzepatide | 15 | $21,266 |
| TrulicityDulaglutide | 18 | $20,685 |
| JardianceEmpagliflozin | 13 | $20,153 |
| FarxigaDapagliflozin Propanediol | 13 | $14,685 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 18 | $10,409 |
| Arnuity ElliptaFluticasone Furoate | 17 | $5,682 |
| Atorvastatin Calcium | 148 | $2,087 |
| Pregabalin | 22 | $1,715 |
| PaxlovidNirmatrelvir/Ritonavir | 14 | $1,429 |
| Lisinopril | 131 | $1,304 |
| Metoprolol Succinate | 53 | $1,140 |
| Fluticasone Propionate | 49 | $1,132 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $306 | $53,34635 claims |
| Lilly USA, LLCMounjaro, Trulicity | $51 | $41,95133 claims |
| Johnson & JohnsonXarelto | $11 | $27,90023 claims |
| PfizerEliquis, Paxlovid | $118 | $25,80639 claims |
| Boehringer IngelheimJardiance | $29 | $20,15313 claims |
| GSKTrelegy Ellipta, Arnuity Ellipta | $167 | $16,09135 claims |
| AstraZenecaFarxiga | $521 | $14,68513 claims |
| AbbVieSynthroid | $510 | $1,01512 claims |
| Almatica Pharma LLCSertraline Hcl | $12 | $55149 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 481 physician assistant providers in Rhode Island.
Other physician assistant in Lincoln
- Stephanie MarlinLincoln$37K
- Alfred LiddleLincoln$23K
- Taylor DrydenLincoln$15K
- Caila PlocharczykLincoln$5K
- Stephen CullenLincoln$4K
- Jennifer GeremiaCranston$370K
- Thomas BalesProvidence$28K
- Maeve TobinPawtucket$21K
- Raquel BertolottiEast Greenwich$13K
- Kathryn WisnewskiPawtucket$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.